SCODiA Report by MLBI Lab

Single-Cell Atlas Reveals Cellular and Molecular Mechanisms of Inflammatory Bowel Disease in the Human Colon

This report presents a comprehensive single-cell analysis of human colon tissue, characterizing cellular heterogeneity and condition-specific responses in Inflammatory Bowel Disease (IBD). Key findings include significant shifts in immune cell populations, particularly the infiltration of activated T cells, B cells, plasma cells, and M1-like macrophages in inflamed tissues. Epithelial cells show profound transcriptional reprogramming, including barrier dysfunction and enhanced immune signaling, while fibroblasts exhibit an activated, pro-fibrotic phenotype. These changes are orchestrated by complex cell-cell interactions and pathway activations, even in non-inflamed regions, underscoring the dynamic and pervasive nature of IBD pathogenesis.

Contents

  1. Dataset overview
  2. UMAP Visualization of Colon Single-Cell Atlas by Condition, Sample, and Cell Type Hierarchies
  3. Major Cell Type Score Visualization on UMAP
  4. Marker Expression Dot Plot for Colon Cell Subsets
  5. Cell Type Population Shifts in Colon Tissue Across Inflammatory Conditions
  6. Population Dynamics of T Cell Subsets and Innate Lymphoid Cells in Colon Inflammation
  7. Condition-Associated Shifts in T Cell Subset Proportions in Human Colon
  8. Macrophage Subset Population Shifts in Colon Inflammation
  9. Differential Macrophage Subset Proportions in Colon across Inflammatory Conditions
  10. Cell-Cell Interaction Patterns in Healthy, Inflamed, and Non-inflamed Colon Tissue
  11. Condition-Specific Cell-Cell Interaction Patterns in Human Colon: Implications for IBD
  12. Condition-Specific Surfaceome Markers in Intestinal Epithelial Cells
  13. Macrophage Condition-Specific Surfaceome Markers in Colon Tissue
  14. Fibroblast Condition-Specific Surfaceome Marker Expression Analysis
  15. CD4+ T Cell Surfaceome Marker Expression Across Colon Conditions
  16. Gene Ontology (GSA) Analysis of Macrophage States in Colon Inflammation
  17. Gene Set Enrichment Analysis (GSEA) Across Colon Cell Types and Inflammatory Conditions
  18. Discussion
  19. Query List

0. Dataset overview

Dataset Summary

Precomputed Results

다음과 같은 사전 계산된 분석 결과가 포함되어 있습니다:

Inferred Biological Context

1. UMAP Visualization of Colon Single-Cell Atlas by Condition, Sample, and Cell Type Hierarchies

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis presents Uniform Manifold Approximation and Projection (UMAP) plots for single-cell RNA-sequencing data from human colon tissue. The UMAPs visualize the cellular landscape, colored by various metadata features: experimental condition (Healthy, Inflamed, Non-inflamed), individual sample, major cell type, minor cell type, and cell type subset. The primary goal is to assess the overall data structure, the separation of biological conditions, potential sample-specific effects, and the quality and resolution of cell type annotations across different hierarchical levels.

Visual Summary

Condition

The UMAP colored by condition shows a notable separation of cells based on their inflammatory status. 'Healthy' cells (dark red) tend to form distinct clusters or reside in specific regions, particularly some of the larger, more diffuse clusters. 'Inflamed' cells (light yellow) are broadly distributed across the UMAP, often mixing with 'Healthy' and 'Non-inflamed' cells but also showing enrichment in certain areas, suggesting condition-specific cellular states or compositions. 'Non-inflamed' cells (dark blue) also show a widespread distribution, with some distinct regions and considerable overlap with both 'Healthy' and 'Inflamed' cells, especially in areas where cell types are broadly represented. This pattern suggests that inflammation induces transcriptional changes that are somewhat distinct, but also highlights shared cellular populations across conditions.

Sample

The sample UMAP reveals good mixing of individual samples across most of the cellular landscape. While some minor sample-specific enrichments might be present in smaller clusters, there are no overt large-scale batch effects where cells from a single sample form isolated, distinct clusters independent of condition or cell type. This indicates that the data integration and dimensionality reduction steps have largely mitigated sample-specific technical variations, allowing for robust biological comparisons.

Cell Type Hierarchies (Major, Minor, Subset)

The UMAPs colored by celltype_major, celltype_minor, and celltype_subset demonstrate a clear and hierarchical organization of cell populations:

Biological Interpretation

The UMAP visualizations provide crucial insights into the cellular heterogeneity and condition-specific responses in the human colon, particularly in the context of inflammation.

  1. Inflammation-driven Cellular Remodeling: The separation of condition suggests that inflammatory processes in the colon lead to distinct changes in cellular states or compositions. While there's significant overlap, especially between 'Healthy' and 'Non-inflamed' (which might represent adjacent non-inflamed areas in IBD patients or individuals without active disease), the 'Inflamed' state likely involves the activation, expansion, or recruitment of specific cell populations that drive the inflammatory phenotype. This aligns with the understanding of Inflammatory Bowel Disease (IBD), where the immune and stromal cell compartments undergo significant remodeling during active inflammation.
  2. High-Resolution Cell Type Identification: The clear hierarchical clustering from celltype_major to celltype_subset demonstrates the high quality of the single-cell data and the robustness of the cell type annotations. The ability to resolve fine-grained cell subsets, such as specific macrophage polarization states (M1, M2 subtypes) or diverse T helper cell lineages (Th1, Th2, Th17, Treg), is critical for understanding the precise cellular contributions to colon homeostasis and disease. For instance, the presence of distinct T helper subsets suggests a complex immune response, and the identification of various epithelial cell types indicates comprehensive sampling of the intestinal lining.
  3. Absence of Major Batch Effects: The effective mixing of sample across the UMAP indicates that any technical variation between samples has been successfully accounted for during data processing. This is vital for ensuring that observed differences between conditions or cell types are genuinely biological rather than artifacts of sample collection or sequencing.

Annotation Notes

The comprehensive and granular cell type annotations across major, minor, and subset levels are a strong asset of this dataset. The clear separation of these annotations in the UMAPs supports their validity and utility for downstream differential expression and pathway analyses. The small fraction of 'unassigned' cells is typical in single-cell datasets and does not detract from the overall high quality of the primary annotations.

2. Major Cell Type Score Visualization on UMAP

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis presents Uniform Manifold Approximation and Projection (UMAP) plots, visualizing the global transcriptional landscape of 88,167 cells from human colon tissue. Each plot (except the last one) displays a 'HiCAT_major_score' for a specific major cell type, indicating the likelihood or transcriptional similarity of cells to that particular cell type. The final plot shows the assigned celltype_major annotation. These visualizations are crucial for assessing the quality of cell type annotation and understanding the distribution and distinctness of different cell populations within the dataset.

Visual Summary

The UMAP projections reveal a well-structured dataset with several distinct clusters, suggesting successful dimensionality reduction and separation of cell populations.

Overall, there is a strong visual concordance between the HiCAT major scores and the assigned celltype_major annotations. Each major cell type score largely illuminates the spatial location of its corresponding annotated cluster, demonstrating good separation and distinctiveness of these major cell populations.

Biological Interpretation

The high concordance between the HiCAT major cell type scores and the celltype_major annotations provides strong evidence for the robust identification and delineation of major cell populations in the human colon single-cell RNA-seq dataset.

  1. Clear Cell Type Delineation: The distinct clustering and concentrated high scores for each major cell type (e.g., T cell, B cell, Myeloid cell, Intestinal Epithelial cell, Stromal cell) indicate that these populations possess unique transcriptional profiles, allowing for their clear separation in the UMAP embedding. This is fundamental for subsequent cell-type-specific analyses.
  2. Tissue-Specific Cell Representation: The presence and relative proportions of these major cell types align with expectations for human colon tissue. The intestinal epithelium is a major component, reflected by the large cluster of Intestinal Epithelial cells. The substantial presence of immune cells (T cells, B cells, Myeloid cells, Mast cells) is expected given the colon's role as a mucosal immune site, especially in the context of inflammatory conditions (as inferred from conditions). Stromal cells (e.g., fibroblasts, smooth muscle cells) and Endothelial cells are crucial structural and vascular components of the colon wall. The detection of Enteric neurons, though a smaller population, highlights the complexity of the colonic microenvironment.
  3. Annotation Confidence: The strong alignment of the HiCAT scores with the celltype_major labels reinforces confidence in the quality of the automated or manual annotation process for these major cell types. Where scores are high, the cells are consistently assigned the corresponding major cell type, and vice versa.
  4. Potential for Granular Analysis: While major cell types are well-defined, areas where scores might be moderately high for more than one cell type (though not prominently visible here) or where a single major cluster might show internal heterogeneity could suggest the presence of minor cell subsets or transitional states, warranting deeper investigation at the celltype_minor or celltype_subset level.

Annotation Notes

The UMAP plots showing HiCAT major scores alongside the celltype_major annotation serve as an excellent validation of the cell type assignment.

3. Marker Expression Dot Plot for Colon Cell Subsets

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis presents a marker expression dot plot for various celltype_subset populations identified in human colon single-cell RNA-seq data. The primary objective is to visually confirm and assess the distinct molecular identities of these cell subsets based on the expression patterns of their top marker genes. The dot plot illustrates both the mean expression level of each gene (color intensity) and the fraction of cells within a given subset that express that gene (dot size). Markers were selected with a focus on surfaceome genes to potentially aid in experimental validation, with genes common across three or more cell groups removed to highlight specificity.

Visual Summary

The dot plot displays a robust diagonal pattern, with prominent red boxes encircling clusters of highly expressed and prevalently expressed genes within corresponding cell types. This diagonal enrichment strongly indicates that each celltype_subset largely expresses a unique set of marker genes, affirming their distinct identities.

Key visual features include:

Biological Interpretation

The marker gene expression patterns broadly align with known cell type identities in the human colon, supporting the annotation of these celltype_subset populations.

Epithelial Lineage

Immune Cell Lineage

Stromal and Endothelial Cells

Annotation Notes

The marker expression patterns observed in this dot plot largely provide strong support for the assigned celltype_subset annotations within the colon tissue. The specificity and high expression of many canonical markers across a broad range of cell types affirm the quality of the cell type identification.

However, certain aspects warrant note:

4. Cell Type Population Shifts in Colon Tissue Across Inflammatory Conditions

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis presents a population bar plot illustrating the relative proportions of minor cell types within individual samples across three conditions: Healthy, Inflamed, and Non-inflamed colon tissue. Each bar represents a single sample, with stacked segments showing the percentage contribution of each identified cell type. This visualization provides insight into how the cellular composition of the colon microenvironment changes in response to inflammatory states, consistent with the inferred context of Inflammatory Bowel Disease (IBD).

Visual Summary

The stacked bar plots reveal distinct patterns of cell type composition across the different conditions:

Biological Interpretation

The observed shifts in cell population proportions provide crucial insights into the underlying biological processes in the colon, particularly in the context of inflammation inferred as Inflammatory Bowel Disease (IBD).

Clinical or Translational Implications

These findings have several important clinical and translational implications for IBD:

5. Population Dynamics of T Cell Subsets and Innate Lymphoid Cells in Colon Inflammation

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis presents a population bar plot illustrating the relative proportions of various T cell subsets, as well as Innate Lymphoid Cells (ILCs) and NK cells, across individual samples from human colon tissue. Samples are grouped by their clinical condition: 'Healthy', 'Inflamed', and 'Non-inflamed'. The plot focuses on the 'T cell' major cell type, further stratified into 'subset' level annotations, providing insight into the immune cell landscape under different inflammatory states.

Visual Summary

The visualization reveals distinct patterns in the composition of T cell and related lymphoid cell subsets across the three conditions:

Biological Interpretation

The observed shifts in T cell and ILC populations are highly relevant to the inferred biological context of Inflammatory Bowel Disease (IBD) in the colon:

Clinical or Translational Implications

The findings have several clinical and translational implications for understanding and managing Inflammatory Bowel Disease:

6. Condition-Associated Shifts in T Cell Subset Proportions in Human Colon

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis investigates the proportional representation of various T cell subsets (specifically T helper cell subtypes and cytotoxic T cells) across different conditions—Inflamed, Non-inflamed, and Healthy—within human colon tissue. Box plots illustrate the distribution of each T cell subset's proportion per condition, with statistical significance indicated for pairwise comparisons. The primary goal is to identify T cell population shifts that characterize inflammatory states, particularly relevant to Inflammatory Bowel Disease (IBD). The p-value cutoff for significance was set at 0.1.

Visual Summary

The box plots reveal distinct patterns of T cell subset proportions across the Inflamed, Non-inflamed, and Healthy conditions:

In summary, inflammatory conditions in the colon are associated with a reduction in Th1, Th2, and Cytotoxic T cell populations, alongside a notable increase in Th17, Treg, Tfh, and Th22 cell populations. These shifts are most pronounced when comparing Inflamed tissue to Healthy tissue, and in some cases, Inflamed tissue also differs significantly from Non-inflamed tissue.

Biological Interpretation

The observed shifts in T cell subset proportions provide key insights into the immune landscape of the inflamed colon, strongly aligning with known immunological changes in Inflammatory Bowel Disease (IBD).

  1. Shift towards Pro-inflammatory T helper responses:
  1. Regulatory and Other Helper T cell dynamics:
  1. Decreased Cytotoxic T cells (T_Cyto): The significant reduction in cytotoxic T cells in the Inflamed colon compared to Healthy tissue is intriguing. While cytotoxic T cells are important for clearing infected or malignant cells, their diminished presence in the inflamed gut could imply tissue exhaustion, migration, or a shift in the primary immune effector mechanisms during chronic inflammation. Alternatively, this population might be highly activated and transiently present, or undergoing apoptosis, leading to an overall lower detected proportion.

Clinical or Translational Implications

These findings have several potential clinical and translational implications for managing Inflammatory Bowel Disease:

References

  1. IL-22 in IBD: A PubMed search for "IL-22 Inflammatory Bowel Disease" provides extensive literature on its dual role. https://pubmed.ncbi.nlm.nih.gov/?term=IL-22+Inflammatory+Bowel+Disease
  2. Treg in IBD: Information on regulatory T cells and their role in immune tolerance and IBD pathogenesis can be found via PubMed. https://pubmed.ncbi.nlm.nih.gov/?term=Regulatory+T+cells+Inflammatory+Bowel+Disease

7. Macrophage Subset Population Shifts in Colon Inflammation

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis presents a population bar plot illustrating the relative proportions of various macrophage subsets (Macrophage M1, M2A, M2B, M2C, M2D) across individual samples from human colon tissue. Samples are grouped by their clinical condition: Healthy, Inflamed, and Non-inflamed. The plot aims to reveal shifts in macrophage polarization that may be associated with inflammatory states, particularly within the context of Inflammatory Bowel Disease (IBD) as inferred from the dataset.

Visual Summary

The visualization displays the percentage contribution of each macrophage subset to the total macrophage population within each sample.

Biological Interpretation

Macrophages are critical immune cells with diverse functions in the colon, ranging from immune surveillance and pathogen clearance to tissue repair and immune regulation. They can polarize into different functional phenotypes, commonly classified as M1 (pro-inflammatory) and M2 (anti-inflammatory, reparative, regulatory).

The observed shift towards a higher proportion of Macrophage (M1) in both "Inflamed" and "Non-inflamed" colon tissue strongly suggests a fundamental alteration in the immunological landscape associated with inflammatory processes. M1 macrophages are characterized by their ability to produce pro-inflammatory cytokines (e.g., TNF-α, IL-1β, IL-6, IL-12) and are crucial for initiating and sustaining immune responses against pathogens or cellular damage [PubMed: Macrophage polarization in inflammatory diseases]. Their enrichment in "Inflamed" tissue is consistent with their role in perpetuating chronic inflammation, a hallmark of IBD.

The finding that "Non-inflamed" colon samples also exhibit an elevated M1 macrophage population is particularly significant in the context of IBD. This could indicate that even macroscopically quiescent or non-inflamed regions in IBD patients are not truly "healthy" at a cellular level, potentially harboring a pre-activated or subclinical pro-inflammatory immune environment. This persistent pro-inflammatory skew, even in the absence of overt inflammation, might contribute to the chronic and relapsing nature of IBD. Conversely, the relative decrease in M2 subsets (which are typically associated with resolving inflammation and promoting tissue repair) could imply an impaired capacity for immune resolution and mucosal healing in IBD.

Clinical or Translational Implications

The distinct macrophage polarization profile observed in "Inflamed" and "Non-inflamed" conditions holds several potential clinical implications for IBD:

8. Differential Macrophage Subset Proportions in Colon across Inflammatory Conditions

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis presents box plots illustrating the celltype proportion of specific macrophage subsets (M2B, M2C, and M2D) in human colon tissue across three conditions: Inflamed, Non-inflamed, and Healthy. The goal is to identify statistically significant differences in the abundance of these subsets between the conditions, particularly in the context of Inflammatory Bowel Disease (IBD), as inferred from the dataset. Statistical significance was determined using a p-value cutoff of 0.1.

Visual Summary

The box plots display the distribution of celltype proportions for three macrophage subsets: Mac (M2B), Mac (M2C), and Mac (M2D), across the three conditions. Individual data points are overlaid on each box plot as a stripplot. P-values indicate the significance of differences between specific condition pairs.

Mac (M2B)

Mac (M2C)

Mac (M2D)

Biological Interpretation

Macrophages are critical immune cells with diverse functions, broadly categorized into M1 (pro-inflammatory) and M2 (anti-inflammatory, pro-resolving, tissue repair) phenotypes, though in vivo, they often exhibit a spectrum of mixed phenotypes. The M2 subtype itself is heterogeneous, with various subsets (e.g., M2a, M2b, M2c, M2d) playing distinct roles. The observed shifts in macrophage subset proportions in the colon tissue across inflammatory conditions provide insights into the underlying immune responses in IBD.

Clinical or Translational Implications

The differential shifts in macrophage subsets observed between healthy, non-inflamed, and inflamed colon tissues highlight the dynamic role of these cells in IBD pathogenesis.

9. Cell-Cell Interaction Patterns in Healthy, Inflamed, and Non-inflamed Colon Tissue

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis visualizes cell-cell interaction (CCI) patterns across different conditions (Healthy, Inflamed, Non-inflamed) in human colon tissue, derived from single-cell RNA sequencing data. The results, generated using CellPhoneDB, highlight significant ligand-receptor interactions between various cell types. Each dot plot displays the top 80 most significant cell-cell communication events (cell pair - ligand-receptor pair combinations) for each condition, ordered by an unspecified metric which typically prioritizes significance and/or strength. The size of each dot corresponds to the negative logarithm of the interaction p-value (-log10(p)), indicating statistical significance, while the color intensity represents the log2(mean) expression level of the interacting ligand-receptor pair, reflecting interaction strength.

Visual Summary

The three dot plots provide a comprehensive view of cell-cell communication dynamics across the three distinct conditions:

Biological Interpretation

The observed cell-cell interaction patterns provide significant biological insights into the dynamics of colon inflammation, particularly in the context of Inflammatory Bowel Disease (IBD).

Key Findings Across Conditions:

  1. Inflamed Colon Exhibits Enhanced Pro-inflammatory and Remodeling Interactions:
  1. Cell Type Specific Contributions to Inflammation:
  1. Non-inflamed Condition Reveals Distinct Metabolic and Maintenance Signals:

Clinical or Translational Implications

The differential cell-cell interaction patterns observed across Healthy, Inflamed, and Non-inflamed conditions in colon tissue offer potential avenues for clinical and translational applications related to IBD:

  1. Therapeutic Target Identification:
  1. Biomarker Discovery:
  1. Understanding Disease Pathogenesis:
  1. Experimental Validation:

10. Condition-Specific Cell-Cell Interaction Patterns in Human Colon: Implications for IBD

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis investigates condition-specific cell-cell interaction (CCI) patterns using CellPhoneDB, comparing 'Healthy', 'Inflamed', and 'Non-inflamed' conditions in human colon tissue. The dot plot visualizes the strength and significance of interactions between major immune and stromal cell types (B cell, T cell, Myeloid cell, Mast cell, Stromal cell, Intestinal Epithelial cell, Endothelial cell) across individual samples. Each dot represents a unique ligand-receptor pair interaction between two cell types (e.g., ADORA3_ENTPD1--Mac|Fib). The color intensity of each dot indicates the scaled log strength of the interaction, while the size of the dot represents its statistical significance (-log10(p-value)). The goal is to identify CCIs that are differentially regulated across inflammatory states, providing insights into potential mechanisms driving Inflammatory Bowel Disease (IBD) pathogenesis.

Visual Summary

The dot plot reveals distinct patterns of cell-cell interactions across the three conditions: Healthy, Inflamed, and Non-inflamed.

Biological Interpretation

The differential CCI patterns highlight key biological processes modulated during colon inflammation, consistent with the inferred context of Inflammatory Bowel Disease (IBD).

  1. Prostaglandin E2 (PGE2) Signaling in Inflammation:
  1. Integrin-Mediated Adhesion and Immune Cell Trafficking:
  1. Chemokine Signaling and Immune Cell Homing:
  1. CEACAM6 Homotypic and Heterotypic Interactions:
  1. Galectin-9 (LGALS9) Signaling:

Clinical or Translational Implications

The identified condition-specific cell-cell interactions offer several potential clinical and translational implications for IBD:

  1. Therapeutic Targeting of Integrins: The widespread and strong activation of integrin-mediated interactions in inflamed and non-inflamed conditions suggests these pathways are central to IBD pathogenesis.
  1. Modulation of Prostaglandin Signaling: The significant role of PGE2 signaling in both inflamed and non-inflamed states points to its complex regulation in IBD.
  1. CXCL12-CXCR4 Axis as a Therapeutic Target: While baseline in healthy, its continued presence in inflamed/non-inflamed may suggest its role in chronic inflammation or fibrosis.
  1. CEACAM6 and Epithelial Homeostasis: The prominent CEACAM6 interactions suggest its role in epithelial changes during inflammation.

These findings underscore the complex interplay between immune and stromal cells in IBD pathogenesis and highlight specific ligand-receptor pairs as promising avenues for therapeutic intervention or as biomarkers for disease activity and response to treatment.

11. Condition-Specific Surfaceome Markers in Intestinal Epithelial Cells

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis identifies and visualizes surfaceome marker expression in Intestinal Epithelial cells across different conditions: Healthy, Inflamed, and Non-inflamed. The dot plot displays the mean expression level (color intensity) and the fraction of cells expressing a given marker (dot size) for selected surface markers. The primary goal is to highlight markers that differentiate the inflammatory state, providing insights into altered epithelial cell biology during intestinal inflammation, such as in Inflammatory Bowel Disease (IBD).

Visual Summary

The dot plot clearly segregates samples based on their inflammatory condition.

Overall, the most striking observation is the profound shift in the surfaceome of Intestinal Epithelial cells in the 'Inflamed' state, characterized by the marked upregulation of numerous cell adhesion molecules, immune-related proteins, and mucins.

Biological Interpretation

The observed differential expression of surfaceome markers in Intestinal Epithelial cells provides critical insights into the molecular mechanisms underlying intestinal inflammation, particularly relevant to Inflammatory Bowel Disease (IBD).

Markers Upregulated in Inflamed Intestinal Epithelial Cells

  1. Immune Presentation and Regulation (HLA-DRB1, HLA-DRA, CD74, CD46):
  1. Cell Adhesion and Barrier Integrity (CEACAM5, CDH1, DSG2, ITGB1, ITGA6, CD44, CRB3, CXADR):
  1. Mucins (MUC1, MUC4, MUC12, MUC13):
  1. Other Notable Markers in Inflamed Cells:

Markers Relatively Higher in Healthy/Non-inflamed Intestinal Epithelial Cells (or decreased in Inflamed)

  1. Transporters (SLC26A3, SLC26A2, AQP8, CA4):

These findings collectively highlight a profound reprogramming of Intestinal Epithelial cell surface characteristics during inflammation, impacting immune interactions, barrier integrity, and homeostatic functions.

Clinical or Translational Implications

The identified condition-specific surfaceome markers in Intestinal Epithelial cells offer several potential avenues for clinical and translational applications in IBD:

Diagnostic and Prognostic Biomarkers:

Therapeutic Targets:

Drug Development:

Further research validating the functional roles of these markers in IBD pathogenesis and exploring their druggability would be crucial for advancing these findings into novel diagnostic tools and therapeutic interventions.

12. Macrophage Condition-Specific Surfaceome Markers in Colon Tissue

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis identifies and visualizes surfaceome markers specific to macrophages in human colon tissue across three conditions: Healthy, Inflamed, and Non-inflamed. The dot plot displays the mean expression level (color intensity) and the fraction of cells expressing the marker (dot size) for individual samples within each condition. This approach helps pinpoint cell surface proteins that characterize macrophage states in different pathological contexts, particularly relevant to Inflammatory Bowel Disease (IBD).

Visual Summary

The dot plot, titled "Macrophage condition-specific markers," effectively illustrates distinct surfaceome profiles for macrophages under Healthy, Inflamed, and Non-inflamed conditions.

In summary, the plot reveals a clear distinction in macrophage surfaceome composition depending on the tissue's inflammatory state. Healthy macrophages are characterized by MHC Class II molecules, while inflamed macrophages exhibit markers associated with active inflammation, oxidative stress, and cell adhesion. Macrophages from non-inflamed tissue show a more unique, albeit sparser, profile with FOLR2 being a prominent distinguishing marker.

Biological Interpretation

The distinct surfaceome marker profiles observed across the Healthy, Inflamed, and Non-inflamed conditions provide critical insights into macrophage functional states in the colon, particularly in the context of Inflammatory Bowel Disease (IBD). Macrophages are central players in gut homeostasis and pathology, responding to microbial stimuli and influencing inflammatory cascades.

Healthy Macrophage Markers:

The markers enriched in healthy colon macrophages suggest a role in maintaining immune surveillance and tissue integrity.

Non-inflamed Macrophage Markers:

Macrophages in the non-inflamed condition, potentially representing a state of remission or a pre-inflammatory stage, show a specific profile.

Inflamed Macrophage Markers:

The extensive list of markers in inflamed macrophages signifies an activated, pro-inflammatory phenotype, characteristic of IBD pathogenesis.

Clinical or Translational Implications

The identification of condition-specific macrophage surfaceome markers has significant clinical and translational implications for Inflammatory Bowel Disease (IBD). These markers can serve as diagnostic biomarkers, tools for monitoring disease activity, or novel therapeutic targets.

Diagnostic and Prognostic Biomarkers:

Therapeutic Targets and Agents:

Overall, these findings highlight the heterogeneity of macrophage populations in IBD and underscore the potential of surfaceome markers for precision medicine approaches, including patient stratification and the development of targeted therapies.

13. Fibroblast Condition-Specific Surfaceome Marker Expression Analysis

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis identifies and visualizes surfaceome marker expression in Fibroblast cells from human colon tissue across three conditions: Healthy, Inflamed, and Non-inflamed. The dot plot displays the mean expression level (color intensity) and the fraction of cells expressing the marker (dot size) for selected surface markers in individual samples within each condition. The goal is to identify markers that are differentially expressed, particularly those associated with inflammatory states, to gain biological insights and potentially identify therapeutic targets. The analysis focuses on surface markers, which are critical for cell-cell communication and accessible to therapeutic intervention.

Visual Summary

The dot plot effectively illustrates the expression patterns of 24 surface markers across 48 individual samples (rows) categorized by condition (Healthy, Inflamed, Non-inflamed).

Condition-Specific Expression Patterns:

Biological Interpretation

Fibroblasts are crucial stromal cells in the colon, playing key roles in tissue homeostasis, wound healing, and pathogenesis of inflammatory and fibrotic diseases like Inflammatory Bowel Disease (IBD). The differential expression of surfaceome markers in colon fibroblasts across conditions provides insights into their activation states and involvement in disease progression.

Markers Upregulated in Inflamed Fibroblasts (Potential IBD-Associated)

Several markers show increased expression and/or prevalence in fibroblasts from Inflamed colon samples, pointing to their involvement in the inflammatory response and tissue remodeling characteristic of IBD.

Markers with Varied Expression

Markers with Higher Expression in Healthy/Non-inflamed Fibroblasts

Clinical or Translational Implications

The identification of differentially expressed surfaceome markers on colon fibroblasts in inflamed conditions offers promising avenues for clinical translation, particularly in the context of IBD.

  1. Biomarkers for Disease Activity and Fibrosis: Upregulated markers like IL6ST, THY1, VCAM1, MMP14, F2R, and CDH11 could serve as biomarkers for fibroblast activation, inflammation severity, or the propensity for fibrosis in IBD. These could potentially be assessed in tissue biopsies to better stratify patients or monitor treatment response.
  2. Novel Therapeutic Targets:
  1. Understanding Fibroblast Heterogeneity: The variable expression patterns, even within the "Inflamed" group, suggest that not all fibroblasts are uniformly activated. Further characterization of fibroblast subsets based on these surface markers could lead to more refined targeting strategies that impact specific pathogenic fibroblast populations.

In summary, the surfaceome markers identified in this analysis provide a rich resource for understanding fibroblast-mediated inflammation and fibrosis in the colon, offering several promising targets for the development of new diagnostic and therapeutic approaches for IBD.

14. CD4+ T Cell Surfaceome Marker Expression Across Colon Conditions

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis presents a dot plot visualizing the expression of selected surfaceome markers within CD4+ T cells across individual samples from healthy, inflamed, and non-inflamed colon tissues. The purpose is to identify condition-specific surface markers that could provide insights into CD4+ T cell states during inflammation, potentially serving as diagnostic biomarkers or therapeutic targets in Inflammatory Bowel Disease (IBD). The plot displays five markers: EMP3, LY6E, PTGER4, CD63, and KLRB1. Dot size represents the fraction of cells expressing the marker within a given sample, while dot color intensity indicates the mean expression level of the marker in those cells. The bar plots on the right show the total number of CD4+ T cells detected in each sample.

Visual Summary

The dot plot reveals distinct expression patterns for surfaceome markers on CD4+ T cells across different conditions (Healthy, Inflamed, Non-inflamed) and individual samples.

Overall Marker Prevalence and Expression:

Condition-Specific Trends:

Biological Interpretation

The observed surfaceome markers provide insights into the functional states and potential roles of CD4+ T cells in the colon, particularly in the context of inflammation associated with IBD.

EMP3 (Epithelial Membrane Protein 3):

LY6E (Lymphocyte Antigen 6 Family Member E):

PTGER4 (Prostaglandin E Receptor 4 / EP4):

CD63 (CD63 Molecule):

KLRB1 (Killer Cell Lectin Like Receptor B1 / CD161):

Clinical or Translational Implications

The differential expression of these surface markers on CD4+ T cells, particularly in the context of Inflammatory Bowel Disease, holds several clinical and translational implications:

  1. Diagnostic and Prognostic Biomarkers:
  1. Therapeutic Targets:
  1. Understanding IBD Pathogenesis:

In summary, this marker expression analysis provides a valuable foundation for hypothesis generation regarding CD4+ T cell function in IBD. PTGER4 and KLRB1, in particular, emerge as markers with significant potential for therapeutic targeting and deeper investigation into disease mechanisms.

15. Gene Ontology (GSA) Analysis of Macrophage States in Colon Inflammation

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis investigates the biological pathways and processes enriched in Macrophage cells across different conditions (Healthy, Inflamed, Non-inflamed) in the human colon, using Gene Ontology (GO) enrichment analysis (GSA). The comparison is performed for each condition against all other conditions, identifying pathways associated with upregulated genes in that specific state. This helps in understanding how macrophage function adapts and shifts in response to varying inflammatory environments, particularly relevant in the context of Inflammatory Bowel Disease (IBD).

Visual Summary

The provided bar plots illustrate the top enriched GO terms (pathways) in Macrophages for three comparative analyses: 'Healthy_vs_others', 'Inflamed_vs_others', and 'Non-inflamed_vs_others'. Terms are ranked by their -log(p-val), with corresponding -log(q-val) for False Discovery Rate (FDR) corrected significance.

Macrophages in Healthy Conditions (Healthy_vs_others)

The first plot, "GSA_up for Macrophage: Healthy_vs_others," shows a striking enrichment of pathways often associated with neurodegenerative diseases such as "Prion disease," "Parkinson disease," "Huntington disease," and "Amyotrophic lateral sclerosis," alongside general cellular processes like "Ribosome," "Oxidative phosphorylation," and "Proteasome." Other significant terms include "Antigen processing and presentation" and various metabolic pathways. The p-values for these top terms are exceptionally low (high -log(p-val) and -log(q-val)), indicating strong statistical significance.

Macrophages in Inflamed Conditions (Inflamed_vs_others)

The second plot, "GSA_up for Macrophage: Inflamed_vs_others," reveals a strong signature of pro-inflammatory and immune-response pathways. Top enriched terms include "Fc gamma R-mediated phagocytosis," "NF-kappa B signaling pathway," "Leishmaniasis" (as an infection model), "Phagosome," and "TNF signaling pathway." Pathways related to leukocyte migration ("Leukocyte transendothelial migration") and various pathogen responses (e.g., "Salmonella infection," "Yersinia infection," "Shigellosis") are also highly significant. Signaling pathways such as "HIF-1 signaling pathway," "Ras signaling pathway," and "MAPK signaling pathway" are also prominent. While many terms show low p-values, the q-values for the top terms are generally lower compared to the 'Healthy_vs_others' comparison, indicating a robust inflammatory signature.

Macrophages in Non-inflamed Conditions (Non-inflamed_vs_others)

The third plot, "GSA_up for Macrophage: Non-inflamed_vs_others," presents a mixed profile. It includes pathways related to infection and immune signaling such as "Coronavirus disease," "Human cytomegalovirus infection," "NOD-like receptor signaling pathway," and "NF-kappa B signaling pathway," similar to the inflamed state, but also a strong emphasis on general cellular maintenance and stress responses. Key terms include "Protein processing in endoplasmic reticulum," "Spliceosome," "RNA surveillance pathway," "RNA degradation," "Apoptosis," and "Mitophagy." While showing significant p-values, the corresponding q-values are generally higher than the other two conditions, suggesting a broader, perhaps less acutely specific, set of activated pathways.

Biological Interpretation

The distinct GO term enrichments provide valuable insights into the functional states of colon macrophages under different health and inflammatory conditions.

  1. Healthy Macrophage Homeostasis: The strong enrichment of terms like "Ribosome," "Proteasome," "Oxidative phosphorylation," and "Antigen processing and presentation" in 'Healthy_vs_others' suggests a role for macrophages in maintaining basal cellular function, protein quality control, and immune surveillance in a non-inflammatory environment. The unexpected prominence of neurodegenerative disease pathways is likely not indicative of neurodegeneration in the colon, but rather points to fundamental cellular processes that are often dysregulated in these conditions (e.g., protein aggregation, mitochondrial dysfunction, oxidative stress, lysosomal activity). In a healthy context, these pathways might reflect a robust capacity for waste management, energy production, and cellular repair, which are essential for preventing the accumulation of cellular damage that contributes to neurodegeneration elsewhere. Therefore, healthy colon macrophages appear to be actively engaged in maintaining cellular integrity and efficient waste disposal.
  2. Inflammatory Macrophage Activation: The 'Inflamed_vs_others' profile is a clear signature of pro-inflammatory M1-like macrophage activation, highly consistent with their role in active inflammatory conditions such as IBD. The enrichment of "Fc gamma R-mediated phagocytosis," "NF-kappa B signaling pathway" [PubMed search: NF-kappa B inflammatory bowel disease], "TNF signaling pathway" [GeneCards: TNF], and infection-related pathways demonstrates their involvement in pathogen clearance, robust immune signaling, and the propagation of inflammatory responses. The activation of "HIF-1 signaling pathway" suggests adaptation to hypoxic microenvironments common in inflamed tissues, further driving inflammatory gene expression. The presence of "Leukocyte transendothelial migration" highlights their role in recruiting other immune cells to the inflammatory site.
  3. Macrophages in Non-inflamed Contexts: The 'Non-inflamed_vs_others' state appears to represent macrophages that are not fully quiescent but also not fully engaged in acute inflammation. The co-occurrence of general cellular maintenance (e.g., "Protein processing in endoplasmic reticulum," "RNA surveillance pathway") with specific immune/infection responses (e.g., "NOD-like receptor signaling pathway" [GeneCards: NOD2], "Coronavirus disease") suggests these macrophages may be involved in ongoing surveillance, mild immune activation, or recovery/remodeling processes. They might be responding to low-grade stressors, viral exposures, or pre-inflammatory signals, actively processing cellular debris, or undergoing adaptations to environmental changes without escalating into a full-blown inflammatory response. This could represent a critical intermediate state in the progression or resolution of IBD.

Clinical or Translational Implications

The distinct functional states of macrophages identified through GSA have significant implications for understanding and managing inflammatory conditions in the colon, such as IBD.

16. Gene Set Enrichment Analysis (GSEA) Across Colon Cell Types and Inflammatory Conditions

Report figure

[Analysis Visualization Results]...

Analysis Overview

This analysis presents Gene Set Enrichment Analysis (GSEA) results, visualized as a dot plot, to identify pathways differentially regulated across various cell types and inflammatory conditions in human colon tissue. The analysis compares gene expression in a specific cell type under one condition (Healthy, Inflamed, or Non-inflamed) against all other conditions combined for that same cell type (e.g., Inflamed B cells vs. Healthy B cells + Non-inflamed B cells). The plot uses dot color to represent the Normalized Enrichment Score (NES), indicating pathway upregulation (red) or downregulation (blue), and dot size to reflect statistical significance (-log(p-value)). This approach allows us to uncover cell-type-specific and condition-dependent biological processes relevant to inflammatory states in the colon.

Visual Summary

The dot plot displays a matrix where the Y-axis lists 120 significantly enriched gene sets (pathways), and the X-axis represents different cell types (celltype_minor) under three comparison conditions: Healthy_vs_others, Inflamed_vs_others, and Non-inflamed_vs_others.

Biological Interpretation

Given the context of human colon tissue with 'Inflamed', 'Non-inflamed', and 'Healthy' conditions, these results strongly support the biological changes characteristic of Inflammatory Bowel Disease (IBD).

Clinical or Translational Implications

These GSEA findings provide critical insights into the molecular mechanisms underpinning IBD, with potential translational implications:

17. Discussion

The single-cell analysis of human colon tissue provides a high-resolution view of the cellular and molecular landscape in Inflammatory Bowel Disease (IBD), revealing profound condition-specific changes that extend beyond overt inflammation. The UMAP visualizations confirm robust cell type annotation and highlight a clear separation of cellular states between healthy, non-inflamed, and inflamed tissues, indicating that inflammatory processes induce distinct transcriptional and compositional shifts.

Cellular Landscape Remodeling in IBD: A central finding is the drastic remodeling of the colon's cellular composition during inflammation. Healthy colon tissue is dominated by Intestinal Epithelial cells, but in inflamed states, there is a marked decrease in their relative proportion, consistent with epithelial damage and displacement. Concurrently, a substantial infiltration and expansion of immune cells — including B cells, plasma cells, T cells (CD4+ and CD8+), Dendritic cells, and Macrophages — are observed. This immune cell accumulation, particularly of B cells and plasma cells, underscores their critical role in local humoral immunity and antibody production in IBD pathogenesis. Notably, even 'Non-inflamed' regions often exhibit an intermediate immune cell profile, suggesting subclinical inflammation or ongoing immune dysregulation.

T Cell and ILC Dysregulation: Detailed analysis of T cell subsets reveals specific proportional shifts. While Th1, Th2, and Cytotoxic T cell proportions decrease in inflamed/non-inflamed conditions relative to healthy, there are significant increases in Th17, Th22, Treg, and Tfh cells in inflamed tissue. The robust elevation of Th17 and Th22 cells is a hallmark of chronic inflammation, driving tissue damage and immune responses. The concomitant increase in Tregs may represent a compensatory mechanism, though their functional efficacy in an inflammatory milieu warrants further investigation. Furthermore, a prominent increase in Innate Lymphoid Cells (ILC1, ILC2, ILC3 (NCR+)) and NK cells in inflamed and some non-inflamed samples highlights ILC dysregulation as a key contributor to chronic inflammation in IBD.

Macrophage Polarization and Immune Dysregulation: Macrophages exhibit a striking shift towards a pro-inflammatory M1-like phenotype in both inflamed and non-inflamed conditions, evidenced by the dominance of M1 macrophage proportions and the enrichment of pathways like Fc gamma R-mediated phagocytosis, NF-kappa B, and TNF signaling. Surface markers like CLEC7A, CD44, CYBB, and ITGB1 are highly upregulated in inflamed macrophages, signifying robust innate immune activation and oxidative stress. Concomitantly, M2 macrophage subsets show complex dynamics: Mac (M2B) and Mac (M2C) increase in inflammation, while Mac (M2D) decreases. The persistent M1 dominance, even in non-inflamed areas, suggests a sustained pro-inflammatory immune environment that may contribute to chronic disease and relapse, while the changes in M2 subsets highlight impaired resolution or altered tissue repair.

Epithelial Barrier Compromise and Remodeling: Intestinal Epithelial cells in inflamed tissue undergo profound transcriptional reprogramming. They upregulate MHC Class II molecules (HLA-DRB1/DRA, CD74), suggesting enhanced antigen-presenting capabilities, which can perpetuate inflammation. Adhesion molecules (CEACAM5, CDH1, DSG2, ITGB1, ITGA6, CD44), mucins (MUC1, MUC4, MUC12, MUC13), and immune modulators (CD47, ADAM15) are also upregulated, indicating significant alterations in epithelial-immune interactions and barrier function. Conversely, functional transporters like SLC26A3/2 and AQP8 are decreased, consistent with impaired fluid and electrolyte balance and overall epithelial dysfunction. GSEA further highlights downregulation of 'Tight junction' components and Oxidative phosphorylation, alongside upregulation of Bacterial invasion and Apoptosis pathways, reinforcing a compromised barrier and metabolic stress.

Fibroblast Activation and Fibrosis: Fibroblasts in inflamed colon tissue exhibit a pro-fibrotic and pro-inflammatory phenotype. Upregulated surface markers include IL6ST (GP130), THY1 (CD90), VCAM1, MMP14, F2R (PAR1), and CDH11. These markers are involved in inflammatory signaling, extracellular matrix remodeling, cell adhesion, and fibroblast activation, contributing to tissue stiffness and potential stricture formation. The activation of pathways such as ECM-receptor interaction, Ras signaling, and PI3K-Akt signaling in fibroblasts and endothelial cells further underscores ongoing tissue remodeling and angiogenesis, characteristic of chronic inflammation and fibrosis in IBD.

Dysregulated Cell-Cell Communication: Cell-cell interaction analyses reveal a significantly enhanced and altered communication network in inflamed tissues. Key interactions include the SPP1-CD44 axis, CXCL12-CXCR4, Prostaglandin E2 signaling (via PTGES3-PTGER2/4), and PDGFA-PDGFRA. Integrin-mediated adhesion (e.g., FN1_integrin_a6b7, VCAM1_integrin_a4b1) between fibroblasts, epithelial cells, and immune cells is robustly active, facilitating immune cell recruitment and tissue remodeling. These interactions represent critical nodes of intercellular crosstalk driving inflammation and tissue pathology.

Metabolic Reprogramming as a Driver of Disease: Beyond individual cell types, a broad metabolic reprogramming is observed. Intestinal epithelial cells show a shift away from oxidative phosphorylation, potentially reflecting adaptation to hypoxic conditions or inflammatory stress. This metabolic inflexibility could impair their regenerative capacity and contribute to barrier dysfunction.

In conclusion, this single-cell atlas delineates the intricate molecular and cellular mechanisms underpinning IBD pathogenesis, highlighting not only immune cell hyperactivation but also crucial roles for epithelial and stromal cells in perpetuating chronic inflammation, barrier dysfunction, and fibrotic remodeling. The observed heterogeneity, particularly in 'Non-inflamed' tissues, underscores the complexity of IBD and the need for targeted interventions that consider the full spectrum of disease states.

Hypotheses:

  1. Chronic inflammation in the colon, characteristic of IBD, drives a shift in T cell differentiation towards pro-inflammatory Th17 and Th22 subsets, while increasing Treg cells to counteract overwhelming inflammation, whose function may be impaired.
  2. Macrophages in both actively inflamed and macroscopically non-inflamed colon tissue adopt a persistent pro-inflammatory M1-like polarization state, which is sustained by specific surface marker expression (e.g., CLEC7A, CD44, CYBB) and pathway activation (e.g., NF-kappa B, TNF signaling), thereby contributing to chronic inflammation and impaired resolution.
  3. Intestinal epithelial cells in IBD exhibit a compromised barrier function, characterized by downregulation of tight junction components and fluid/electrolyte transporters (e.g., SLC26A3, AQP8), coupled with increased immune antigen presentation (e.g., HLA-DRB1/DRA) and susceptibility to bacterial invasion, actively contributing to perpetuating inflammation.
  4. Fibroblasts in the inflamed colon undergo significant activation and differentiation into myofibroblast-like cells, marked by increased expression of IL6ST, THY1, VCAM1, and MMP14, which drives extracellular matrix remodeling and promotes pathogenic immune cell recruitment and tissue fibrosis.
  5. Specific cell-cell interaction axes, such as SPP1-CD44, CXCL12-CXCR4, and various integrin-ligand pairs (e.g., VCAM1-integrin_a4b1), are dysregulated in inflamed colon, acting as critical communication hubs between immune, epithelial, and stromal cells to propagate inflammation and drive tissue pathology.
  6. The observed metabolic reprogramming, particularly the downregulation of oxidative phosphorylation in inflamed intestinal epithelial cells, indicates a shift towards altered energy metabolism that impairs epithelial barrier integrity and regenerative capacity, contributing to IBD pathology.

Potential therapeutic targets:

  1. Integrins (e.g., α4β1, α4β7, α6β7, α1β1) / VCAM1: Integrin-mediated adhesion and VCAM1 expression are profoundly upregulated in inflamed and non-inflamed colon tissue, particularly on fibroblasts, macrophages, and epithelial cells. These interactions facilitate immune cell trafficking, tissue remodeling, and epithelial-stromal crosstalk, critically driving inflammation and fibrosis in IBD. Evidence: Increased VCAM1_integrin_a4b1_complex--Fib|Mac and FN1_integrin_a6b7_complex--Fib|Ent.Epi interactions are highly active in Inflamed and Non-inflamed conditions (Section 10). Macrophages show upregulated ITGB1 in inflammation (Section 12). Fibroblasts show upregulated VCAM1 (Section 13). GSEA indicates upregulation of 'ECM-receptor interaction' (Section 16). Validation: Test existing integrin inhibitors (e.g., Vedolizumab (α4β7), Natalizumab (α4)) in IBD animal models or clinical trials with a focus on specific cell populations and fibrotic outcomes. Develop novel antibodies or small molecules against VCAM1 itself or other key integrin subunits (e.g., α6, β1, α1) and evaluate their efficacy in organoid/co-culture models and patient biopsies via functional assays and immunostaining.
  2. IL-6/GP130 Signaling Pathway (IL6ST): IL-6 signaling is a potent driver of chronic inflammation and fibrosis. Upregulation of the GP130 receptor subunit (IL6ST) on fibroblasts in inflamed tissue indicates heightened responsiveness to IL-6, promoting fibroblast activation, proliferation, and extracellular matrix production. Evidence: IL6ST is markedly higher on fibroblasts in Inflamed samples (Section 13). GSEA shows upregulation of 'JAK-STAT signaling pathway' (which IL-6 uses) in multiple immune cell types during inflammation (Section 16). Validation: Evaluate the efficacy of existing IL-6R blocking antibodies (e.g., tocilizumab, sarilumab) in IBD patients, specifically monitoring fibroblast activation markers (e.g., THY1, MMP14) in biopsies. Develop novel strategies directly targeting GP130 on stromal cells and test in fibroblast culture models or fibrosis-prone animal models of IBD.
  3. Prostaglandin E Receptor 4 (PTGER4 / EP4): PGE2 is a critical lipid mediator of inflammation, and its receptor PTGER4 is expressed on CD4+ T cells, where its activation can promote Th17 differentiation and suppress Treg function, contributing to inflammation in the gut. PGE2 signaling is also a prominent cell-cell interaction in inflamed colon. Evidence: PGE2 signaling is a strong and significant cell-cell interaction in inflamed colon (Section 9 & 10). PTGER4 is present on CD4+ T cells with variable expression, showing potential for modulation in inflammation (Section 14). Validation: Administer selective EP4 antagonists in IBD animal models and assess their impact on Th17/Treg balance, cytokine production, and overall gut inflammation. Evaluate PTGER4 expression and signaling in patient-derived T cells and test the effects of EP4 modulation on their inflammatory responses in vitro.
  4. CLEC7A (Dectin-1): CLEC7A is a C-type lectin receptor highly expressed on macrophages in inflamed tissue, indicating robust innate immune activation and initiation of downstream pro-inflammatory signaling pathways (e.g., NF-κB), contributing to excessive inflammation in IBD. Evidence: CLEC7A is a key surface marker highly expressed in inflamed macrophages (Section 12). Macrophages in the inflamed condition show strong enrichment of 'NF-kappa B signaling pathway' (Section 15). Validation: Develop inhibitors or blocking antibodies against CLEC7A and test their effect on macrophage activation, cytokine production, and inflammation in ex vivo colon explants from IBD patients or in IBD animal models. Monitor downstream NF-κB activation.
  5. CXCL12-CXCR4 Axis: The CXCL12-CXCR4 axis is critical for immune cell trafficking and retention. Its sustained activity in inflamed and non-inflamed colon, particularly involving fibroblasts and T cells, suggests its role in promoting immune cell infiltration and potentially contributing to chronic inflammation and fibrosis in IBD. Evidence: CXCL12-CXCR4 is a strong and significant cell-cell interaction in healthy, inflamed, and non-inflamed conditions, specifically Fib|T CD4+ (Section 9 & 10). Validation: Investigate the efficacy of CXCR4 antagonists (e.g., Plerixafor or novel compounds) in preclinical IBD models to reduce immune cell infiltration and assess impacts on inflammation and fibrosis. Use flow cytometry to track CXCR4+ immune cells in colon biopsies from treated patients.

Follow-up validation ideas:

  1. Flow Cytometry/Immunostaining: Quantify the proportions of Th17, Th22, Treg, and ILC subsets (ILC1, ILC2, ILC3 (NCR+)) in fresh colon biopsies from IBD patients and healthy controls to validate the observed population shifts. Use specific surface markers (e.g., KLRB1 for a subset of CD4+ T cells) to confirm differential expression and localization within the inflamed mucosa.
  2. Spatial Transcriptomics/Immunofluorescence: Investigate the spatial distribution and co-localization of M1-like macrophages (e.g., expressing CLEC7A, CD44, CYBB), activated fibroblasts (e.g., THY1+, VCAM1+), and epithelial cells expressing MHC Class II (e.g., HLA-DRB1/DRA) in inflamed versus non-inflamed colon tissues to confirm their proximity and potential for direct cell-cell interactions. This can validate key CCI findings.
  3. Organoid/Co-culture Models: Develop patient-derived intestinal epithelial organoids or co-culture systems with macrophages and fibroblasts, simulating inflamed conditions. Perturb specific signaling pathways (e.g., using inhibitors for NF-kappa B, TNF, IL-6, or specific integrins like ITGB1) or block identified ligand-receptor interactions (e.g., SPP1-CD44, VCAM1-integrin) to assess their impact on epithelial barrier integrity, cytokine production, macrophage polarization, and fibroblast activation.
  4. Targeted qPCR/Western Blot: Validate the differential expression of key surface markers (e.g., SLC26A3, AQP8, CEACAM5, MUC1, PTGER4, KLRB1) in sorted epithelial cells, macrophages, fibroblasts, and T cells from IBD patient biopsies versus controls. This provides orthogonal confirmation of the scRNA-seq findings at the protein or mRNA level.
  5. Functional Assays for Epithelial Barrier: Conduct transepithelial electrical resistance (TEER) measurements and dextran permeability assays on epithelial cell monolayers or organoids after specific pathway perturbations (e.g., targeting tight junction components or mucins, or co-culturing with activated immune cells) to functionally validate epithelial barrier dysfunction in IBD.
  6. In Vivo Animal Models: Utilize genetically modified mouse models of IBD (e.g., IL-10 knockout, DSS-induced colitis) or humanized mouse models to test the efficacy of blocking agents (e.g., anti-IL6ST, anti-VCAM1, anti-CLEC7A, PTGER4 antagonists) targeting identified therapeutic candidates on disease progression, inflammation resolution, and fibrosis development. Assess cellular infiltrates and gene expression changes in response to treatment.
  7. Single-Cell Validation Cohorts: Apply the identified cellular and molecular signatures (e.g., M1 macrophage polarization markers, Th17/Th22 T cell profiles, epithelial barrier gene expression) to an independent cohort of IBD patients using single-cell RNA-seq or multiplexed spatial proteomics to confirm generalizability and prognostic value.
  8. Metabolic Flux Analysis: Perform metabolic profiling (e.g., Seahorse assay) on sorted intestinal epithelial cells from healthy and inflamed colon to confirm the shift away from oxidative phosphorylation and explore alternative metabolic pathways, providing functional validation of the observed metabolic reprogramming.

Limitations:

This report is based on single-cell RNA sequencing data, which provides valuable insights into cell states and interactions but has inherent limitations. The analysis infers cell-cell interactions and pathway activities from gene expression, which may not always directly reflect functional protein interactions or signaling kinetics. The 'Non-inflamed' condition, particularly in the context of IBD, can be highly heterogeneous, potentially encompassing quiescent disease, subclinical inflammation, or areas affected by past inflammation, leading to varied cellular and molecular profiles that are challenging to distinguish without comprehensive clinical staging. The dataset, while extensive, is a snapshot in time and does not capture the dynamic progression of IBD. The use of surfaceome-only markers in some analyses might exclude crucial intracellular regulators. Furthermore, while the inferred disease is Inflammatory Bowel Disease, the specific subtype (Crohn's disease vs. Ulcerative Colitis) or clinical severity cannot be definitively determined from the provided metadata alone. Therapeutic target suggestions are based on correlative findings and literature; their functional validation and clinical translation require extensive experimental and clinical trials.

18. Query List

  1. Show and save UMAPs for condition, sample, major cell type, minor cell type, and celltype_subset in two columns.
  2. Show major cell type scores on UMAP and save the result.
  3. Show and save a marker expression dot plot for celltype_subset. SET target_cell = None and var_group_rotation = 45. Leave all other arguments at their default values.
  4. Show and save a population bar plot of minor cell types.
  5. Show and save a population bar plot of T cell subsets.
  6. Show and save box plots of T cell subset populations with statistically significant differences between conditions, if any. Choose ncols based on the total number of panels.
  7. Show and save a population bar plot of macrophage subsets.
  8. Show and save box plots of macrophage subset populations with statistically significant differences between conditions, if any. Choose ncols based on the total number of panels.
  9. Show and save cell-cell interaction patterns. Select at most 80 cell-cell interactions per group.
  10. Find cell-cell interactions involving major immune and stromal cells that differ significantly between conditions, show them as a dot plot, and save the result. Set max_n_items_per_group to 60. For each interaction identified under each condition, using the provided dataset context, describe the associated signaling pathways and mechanisms and, where relevant, its potential as a therapeutic target and related therapeutic agents.
  11. Show marker expressions for Intestinal Epithelial cell in a dot plot, and save the result. Use only surfaceome markers, with at most 50 markers per condition. For each marker identified under each condition, using the provided dataset context, describe the associated signaling pathways and biological mechanisms within the tissue and, where relevant, its potential as a therapeutic target for the disease and related therapeutic agents.
  12. Show marker expressions for Macrophage in a dot plot, and save the result. Use only surfaceome markers, with at most 40 markers per condition. For each marker identified under each condition, using the provided dataset context, describe the associated signaling pathways and biological mechanisms within the tissue and, where relevant, its potential as a therapeutic target for the disease and related therapeutic agents.
  13. Show marker expressions for Fibroblast in a dot plot, and save the result. Use only surfaceome markers, with at most 40 markers per condition. For each marker identified under each condition, using the provided dataset context, describe the associated signaling pathways and biological mechanisms within the tissue and, where relevant, its potential as a therapeutic target for the disease and related therapeutic agents.
  14. Show marker expressions for T cell CD4+ in a dot plot, and save the result. Use only surfaceome markers, with at most 40 markers per condition. For each marker identified under each condition, using the provided dataset context, describe the associated signaling pathways and biological mechanisms within the tissue and, where relevant, its potential as a therapeutic target for the disease and related therapeutic agents.
  15. Show Gene Ontology (GSA) analysis results for Macrophage as a bar plot, and save the result.
  16. Show Gene Set Enrichment Analysis results as a dot plot, and save it. Set the color map to RdBu_r, n_pws_to_show to 120, and target_cells to None.
↑ Top